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Abstract
Breathing is enabled by lung surfactant, a mixture of proteins and lipids that forms a surface-active layer and reduces
surface tension at the air-water interface in lungs. Surfactant protein B (SP-B) is an essential component of lung surfactant. In
this study we probe the mechanism underlying the important functional contributions made by the N-terminal 7 residues of
SP-B, a region sometimes called the ‘‘insertion sequence’’. These studies employed a construct of SP-B, SP-B (1–25,63–78),
also called Super Mini-B, which is a 41-residue peptide with internal disulfide bonds comprising the N-terminal 7-residue
insertion sequence and the N- and C-terminal helices of SP-B. Circular dichroism, solution NMR, and solid state 2H NMR were
used to study the structure of SP-B (1–25,63–78) and its interactions with phospholipid bilayers. Comparison of results for
SP-B (8–25,63–78) and SP-B (1–25,63–78) demonstrates that the presence of the 7-residue insertion sequence induces
substantial disorder near the centre of the lipid bilayer, but without a major disruption of the overall mechanical orientation
of the bilayers. This observation suggests the insertion sequence is unlikely to penetrate deeply into the bilayer. The 7-
residue insertion sequence substantially increases the solution NMR linewidths, most likely due to an increase in global
dynamics.
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Introduction
Lung surfactant is a complex of lipids and proteins that lines the
air-water interface at the alveolar surface. It is essential for
reducing surface tension and preventing alveolar collapse [1,2].
Lung surfactant has a complex composition and forms dynamic
and intricate two dimensional and three dimensional structures,
with a monolayer at the interface as well as associated multilayer
structures underneath [3–7]. Deficiency or inactivation of lung
surfactant leads to potentially lethal respiratory disorders such as
neonatal respiratory distress syndrome (NRDS) in premature
newborns [8–10] and acute respiratory distress syndrome (ARDS)
in patients with severe injury or illness [11–13]. Surfactant
replacement therapy has been quite successful in treating NRDS
[14,15]. However, efforts to use replacement surfactant to treat
ARDS have not demonstrated improvements in mortality rates
thus far [9,12].
Approximately 90% by weight of surfactant is lipid, mainly
phosphocholine (PC) and phosphoglycerol (PG), and 10% is
surfactant proteins (SPs) [3,16–18]. SPs are designated by their
chronologic order of discovery as SP-A, SP-B, SP-C, and SP-D
[19]. SP-A and SP-D are water soluble and important for host
defense [20,21], whereas SP-B and SP-C are smaller, hydrophobic
proteins that are critical for reducing surface tension during
breathing [22,23]. SP-B is the only essential protein component of
lung surfactant, as evidenced by the lethality of hereditary SP-B
deficiency in humans [24,25] and the lethal effect of knocking out
the SP-B gene in mice [26].
SP-B is a highly conserved member of the saposin superfamily
of proteins and thus expected to possess 4 to 5 helices [23,27]. It is
found in the lung as a covalently linked homodimer, with 79
amino acid residues in each monomer. Three intramolecular
disulfide bonds are formed by six cysteines, and a seventh cysteine
forms an intermolecular bridge to stabilize the SP-B homodimer
structure. SP-B has a large proportion (52%) of hydrophobic
amino acids, and also has cationic characteristics with a net charge
of +7 (per monomer) at neutral pH. Its positive charge and highly
hydrophobic nature are thought to provide the basis for
interactions between SP-B and the negatively charged lipid
components of lung surfactant. A number of potential mechanisms
for SP-B have been proposed including providing a link between
the monolayer and underlying bilayers, stabilizing lipid structures
required for lowering surface tension, promoting transfer of lipids
into and out of functional lipid structures, and promoting
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interfacial adsorption of surfactant from the hypophase to the air–
water interface [6,7,28–31]. However, SP-B’s three-dimensional
structure has not yet been determined, which is an impediment to
understanding its detailed mechanism.
In an alternate approach, a number of studies have addressed
structure/function relationships in fragments of SP-B that retain a
substantial portion of the function of the full length protein [32–
36]. NMR structures of some of the individual helices of SP-B
have been determined [37,38]. A structure has also been
determined for a larger fragment, termed Mini-B, which retains
two of SP-B’s four helices (residues 8–25 and 63–78) and much of
its function, as assessed by measurements in surfactant-deficient
rats [39,40].
The region of SP-B’s N-terminus preceding the first helix,
termed the ‘‘insertion sequence’’ [41,42], is of particular interest.
The segment of SP-B comprising residues 1–7, Phe-Pro-Ile-Pro-
Leu-Pro-Tyr, resembles proline-rich cell-penetrating peptides
[43]. Proline is very singular amongst the set of natural amino
acids in that it lacks a backbone HN group to form hydrogen
bonds, has a ring structure that restricts its allowable backbone
dihedral angles, and has a propensity to form special secondary
structures, such as polyproline II helix. The functional role of the
insertion sequence has been probed in the context of N-terminal
peptides of SP-B and it was found that mutation of any of the
proline residues led to decreased surface activity [44]. More
recently, the insertion sequence has been examined by adding it on
to Mini-B, to create a construct of SP-B, termed ‘‘Super Mini-B’’
(SP-B (1–25,63–78)), which retains the N-terminal insertion
sequence, two of the four SP-B helices, specifically the N-terminal
helix and the C-terminal helix, the two disulfide bonds that help
link the helices together, and an overall charge of +7 [41,42]. The
7 insertion sequence residues, along with the tryptophan at
position 9, were proposed to stabilize the formation of ‘‘nanosilos’’,
structures seen by atomic force microscopy imaging of monolayers
deposited at high surface pressures [41]. In this study, we further
probe the role of SP-B residues 1–7, by comparing the structure
and lipid interactions of the construct that includes the insertion
sequence, SP-B (1–25, 63–78) (Super Mini-B), with those of a
construct lacking this sequence, SP-B (8–25,63–78) (Mini-B), as
well as by characterizing the structural features of SP-B (1–7) by
itself.
Materials and Methods
Materials
SP-B (1–25,63–78) (FPIPLPYCWLCRALIKRIQA-
MIPKGGRMLPQLVCRLVLRCS), SP-B (8–25,63–78)
(CWLCRALIKRIQAMIPKGGRMLPQLVCRLVLRCS) and
SP-B (1–7) (FPIPLPY) were prepared by solid phase synthesis
using Fmoc (O-fluorenylmethyl-oxycarbonyl) chemistry as in [41].
The peptides were purified using reversed-phase HPLC and the
masses were confirmed by MALDI-TOF spectroscopy. Purity of
the sample was determined to be $95% by analytical HPLC.
Sodium-dodecylsulfate-d25 was purchased from Cambridge Iso-
tope Laboratories (Andover, MA) and sodium-dodecylsulfate and
sodium azide from Sigma-Aldrich. The phospholipids 1-palmitoyl
(d31)-2-oleoyl-sn-glycero-3-phosphocholine (POPC-d31) and 1-pal-
mitoyl-2-oleoyl-sn- glycero-3-[phospho-rac-(1-glycerol)] (sodium
salt) (POPG), were purchased from Avanti Polar Lipids, Inc.
Solid-state NMR
2H NMR was used to observe the perturbation of mechanically-
oriented phospholipid bilayers by SP-B (1–25,63–78). To prepare
oriented samples, 1 mol% peptide, if present, was co-dissolved
with 4 mg of a 7:3 (molar ratio) mixture of POPC-d31 and POPG
in a mixture of CH3OH/CHCl3 (1:1 by volume). The solution,
comprising a total volume of 250 ml, was spread onto 12 mica
plates (12 mm by 12 mm) by depositing ,1 ml at the centre of
each plate, allowing 3–5 minutes for spreading and drying, and
then repeating until the deposition of the full volume was
complete. The films on the mica plates were then dried for
2 hours in a fume hood after which residual solvent was removed
by exposure to vacuum for,8 hours. Films were then hydrated by
spreading 5 mL of deuterium-depleted water onto each plate and
then leaving the plates in a hydration chamber, along with
saturated ammonia phosphate solution, at 4uC for 2 days. The
plates were then carefully stacked, wrapped with plastic film, and
sealed in heavy plastic wrap. Samples were stored at 4uC before
the NMR experiments.
2H-NMR spectra were obtained using a locally-assembled
spectrometer operating at 61.4 MHz. The oriented samples were
positioned in a flat coil (15 mm615 mm63 mm) with the bilayer
normal parallel to the magnetic field of a 9.4 T superconducting
solenoid. Spectra were derived from free-induction decays
obtained by averaging 60000 transients accumulated using a
quadrupole echo sequence [45] with a p/2 pulse length of 4.1 ms
and 30 ms pulse separation. Transients were acquired using a
digitizer dwell time of 1 ms and oversampling [46] by a factor of 4
to give an effective dwell time of 4 ms. All 2H-NMR spectra were
acquired at 23uC.
The 2H-NMR spectrum of POPC-d31 in a liquid crystalline
bilayer oriented with its normal at an angle b with respect to the
applied magnetic field is a superposition of spectral doublets with
quadrupole splittings given by
Dni~
3
4
e2qQ
h
3 cos2 b{1
 
SiCD
Figure 1. 2H spectra of mechanically oriented 7:3 POPC-
d31:POPG bilayers in the presence (upper panel) and absence
(lower panel) of 1 mol% SP-B (1–25,63–78). The spectra were
acquired with 60000 transients at 23uC. Dashed vertical lines indicate
the quadrupole splitting of deuterons on the C15 acyl chain segment of
POPC-d31 in the absence of SP-B (1–25,63–78).
doi:10.1371/journal.pone.0072821.g001
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where
e2qQ
h
~167kHz is the quadrupole coupling constant for
carbon-deuterium bonds and SiCD is the orientational order
parameter for deuterons on the acyl chain methylene group
denoted by i. For a given carbon-deuterium bond, the orienta-
tional order parameter is given by
SCD~
1
2
S3 cos2 h{1T
where h is the angle between the direction of the carbon-
deuterium bond and the bilayer normal which is the symmetry
axis for fast, axially symmetric reorientation of the lipid acyl chain
in the liquid crystalline phase. The average is over all motions and
chain conformational changes that modulate the quadrupole
interaction on the approximately 1025 s timescale of the 2H-
NMR. For a saturated phospholipid acyl chain, the orientational
order parameter is largest at the headgroup end of the chain,
where motions are most constrained, and decreases with position
along the chain to the methyl group near the bilayer centre where
motions are least constrained. The dependence of orientational
order parameter on position along the chain is characterized by
the orientational order parameter profile [47,48].
For a mechanically-oriented sample with bilayer normal parallel
to the magnetic field, b= 0u and the spectrum is a superposition of
sharp doublets with quadrupole splittings given by
DniCD~
3
2
e2qQ
h
SiCD
For unoriented bilayers, such as in a multilamellar vesicle
sample, the bilayer normal directions are spherically distributed
and the spectrum is a superposition of Pake doublets with
prominent edges, for each position along the chain, corresponding
Figure 2. Half 2H NMR spectra of mechanically oriented 7:3
POPC-d31:POPG bilayers in the absence of peptide (a), in
comparison to (b) with 1 mol% SP-B (8–25,63–78) or (c) SP-B
(1–25,63–78). The spectra were all acquired at 23uC. Vertical lines
indicate the quadrupole splitting of POPC-d31 deuterons in the absence
of peptide.
doi:10.1371/journal.pone.0072821.g002
Table 1. Splittings, D n, and corresponding order parameters, SCD, for the resolved peaks of the 2H NMR spectra of POPC-d31/
POPG (7:3) (Figure 1) in the absence and presence of SP-B (1–25,63–78) (Super Mini-B).
C15 C14 C13 Plateau
D n (kHz) SCD D n (kHz) SCD D n (kHz) SCD D n (kHz) SCD
Without SP-B (1–25,63–78) 19.860.8 0.079 26.460.9 0.11 31.460.9 0.13 52.561.2 0.21
With SP-B (1–25,63–78) 16.760.8 0.066 22.560.9 0.090 26.760.9 0.11 50.361.2 0.20
The splittings quoted derive from a single experiment; however the uncertainty has been estimated based on the standard deviation in splittings derived from 5
separate control experiments with the same lipid composition.
doi:10.1371/journal.pone.0072821.t001
Figure 3. A) Far-UV CD spectra of SP-B (8–25,63–78) (triangles),
SP-B (1–25,63–78) (circles) and SP-B (1–7) (squares) dissolved
in SDS micelles. Spectra were taken using a 1 mm path-length quartz
cuvette from 200 nm to 260 nm at 25uC. Shown are single scans. Three
additional spectra of each sample were acquired and the 4 scans
averaged together before % secondary structure was extracted
(Table 2).
doi:10.1371/journal.pone.0072821.g003
Role of the N-Terminal Seven Residues of SP-B
PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e72821
to b= 90u and thus half the splitting of the corresponding doublet
in the oriented bilayer spectrum.
2.2 Circular dichroism (CD)
The same peptide samples were used for solution NMR and for
CD. SP-B (1–25,63–78), SP-B (8–25,63–78) and SP-B (1–7) in
SDS micelles were prepared by dissolving 1 mM peptide and
150 mM deuterated SDS (98% deuterated, Cambridge Isotope
Laboratories) in 90% H2O and 10% D2O. The sample also
included 0.2 mM 2,2-dimethyl-2-silapentane-5-sulfonate (sodium
salt, DSS) and 0.2 mM sodium azide. The pH was adjusted to 5.0.
The CD spectra were acquired on a Jasco J–810 spectropolarim-
eter (Applied Photophysics, UK). The absorbance at 222 nm was
checked for each sample to ensure that it did not exceed an optical
density of 1.0. A 1 mm cell was used and spectra were collected
between wavelengths of 200 and 260 nm at 308 K. Baselines were
established using the appropriate buffer and the means of 4 spectra
were analyzed. Secondary structure content was calculated from
the spectra using CDPro software (http://lamar.colstate.edu/
s˜sreeram/CDPro) developed by Woody and co-workers (Sreerama
and Woody, 1993). CD values were converted to mean residue
ellipticity (MRE). Basis set 2 of the CDPro software was used and
analysis was performed using CONTIN/LL method [49].
Solution NMR
The same samples used for the CD observations of SP-B (1–
25,63–78) were also employed in the solution NMR experiments.
Data was acquired on a Bruker Avance 600 MHz spectrometer
equipped with z-gradients and a triple-resonance TXI probe. The
1D 1H experiments were run with 32 transients, and a recycle
delay of 1 second, with watergate water suppression, at 37 and
45uC. 2D-TOCSY experimental parameters included a mixing
time of 80 ms, acquisitions of 96 transients for SP-B (1–25,63–78)
and 128 transients for SP-B (8–25,63–78), with 1024 points in the
direct dimension, 480 points in the indirect dimension, and water-
gate water suppression. 2D-NOESY experiments were run with a
mixing time of 200 ms, 160 transients for SP-B (1–25,63–78) and
128 transients for SP-B (8–25,63–78), 1024 points in the direct
dimension, 512 points in the indirect dimension, and water-gate
water suppression. The chemical shifts were referenced with
respect to an internal DSS standard (0.0 ppm). The data was
processed with iNMR (http://www.inmr.net) and analyzed using
Sparky [50].
Diffusion-ordered spectroscopy (DOSY) experiments were
performed on the same Bruker Avance 600 MHz spectrometer
employing pulsed field gradient (PFG) NMR [51] with the same
SP-B (1–25, 63–78) SDS sample. The pulse sequence used a
stimulated echo with bipolar gradient pulses and one spoil gradient
[52] followed by a 3–9–19 pulse for water suppression [53]. The
1H signals were attenuated to ,5% of their initial amplitudes by
increasing the gradient strength from ,2% to 95% in 32 steps.
Experiments were performed at 37uC. The pseudo 2D DOSY
spectra were processed using iNMR and the diffusion constants
extracted using the DECRA package of DOSYToolbox [54].
Results
2H NMR of SP-B (1–25,63–78) in oriented lipid bilayers
The effects of SP-B (1–25,63–78) on lipid bilayer orientation
and chain orientational order were investigated by 2H NMR.
Figure 1 shows spectra of POPC-d31/POPG (7:3) with and
without SP-B (1–25,63–78). In the absence of peptide, the doublets
are sharp and well resolved, indicating that the lipid bilayers are
well aligned. With the incorporation of 1 mol% SP-B (1–25,63–
78), the distribution of spectral area across the spectrum shifts in a
way that suggests the emergence of a weak spectral component
corresponding to a more random distribution of bilayer normal
directions - i.e. Pake quadrupole doublets split by half of the
corresponding oriented sample doublet splittings. Doublets in the
oriented component of the spectrum also broaden in a way
consistent with increased mosaic spread [55]. The presence of SP-
B (1–25,63–78) thus appears to disrupt the mechanical orientation
in a small fraction of the bilayer material.
More conspicuous, however, is the effect of SP-B (1–25,63–78)
on the quadrupole splittings, and hence chain orientational order,
Table 2. Percent secondary structure content of SP-B (1–25,63–78) (Super Mini-B), SP-B (8–25,63–78) (Mini-B) and SP-B (1–7) (the
insertion sequence) in SDS micelles calculated from CD spectra (average of 4 scans).
Secondary Structure (%) a-helix 310-helix b-Sheet Turn Polyproline II Unordered
SP-B (1–25,63–78) (Super
Mini-B) ContinLL Method
24 7 13 14 6 36
SP-B (1–25,63–78) (Super
Mini-B) K2D Method
29 – 16 – – 55
SP-B (8–25,63–78) (Mini-B)
ContinLL Method
37 9 13 5 30
SP-B (8–25,63–78) (Mini-B)
K2D Method
42 – 16 – – 41
Deconvolution of CD spectra was accomplished using CDPro, with basis set 2 and the CONTIN/LL algorithm [49] and also with the K2D method [52].
doi:10.1371/journal.pone.0072821.t002
Figure 4. HN region of the 1H NMR spectra of 1 mM SP-B (1–
25,63–78) in SDS micelles at 456C (red) and 1.5 mM SP-B (8–
25,63–78) in SDS micelles at 376C (blue). The number of transients
was 32. The intensity scale is arbitrary but has been normalized to take
into account the differences in peptide concentration.
doi:10.1371/journal.pone.0072821.g004
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of that portion of the lipid bilayer material that does remain
oriented. The vertical lines in Figure 2 indicate the quadrupole
splitting of deuterons of POPC-d31 in the absence of SP-B (1–
25,63–78). The quadrupole splitting for the C15 deuterons, just
adjacent to the methyl group at the tail end of the lipid chains, as
well as the C14 and C13 deuteron splittings, are substantially
reduced in the presence of SP-B (1–25,63–78) (Figure 2c). While
more difficult to resolve, the largest quadrupole splittings,
corresponding to deuterons in the so-called plateau region near
the headgroup end of the acyl chain, are also reduced by the
presence of the SP-B (1–25, 63–78). The splittings and
corresponding order parameters are quantified in Table 1. SP-
B (1–25,63–78) is thus seen to increase orientational disorder along
the entire lipid acyl chain and particularly near the centre of the
bilayer.
Structural Characteristics of SP-B (1–25,63–78) in SDS
micelles
Circular dichroism (CD) experiments were carried out with SP-
B (1–25,63–78) in SDS micelles, and, for comparison, with SP-B
(8–25,63–78) and SP-B (1–7) in SDS micelles (Figure 3). The
secondary structure percentages were calculated from the spectra
using two different methods, ContinLL with reference protein set
SP22X [49] which fits the CD data using 5 types of secondary
structure, as well as K2D [56], which uses only three secondary
structure types in the fit (Table 2). Both methods indicate that SP-
B (1–25,63–78) possesses a smaller fraction of helical structure and
a greater fraction of unstructured residues, compared to SP-B (8–
25,63–78). The decrease in the fraction of helical structure in the
longer peptide is as expected given that the solution NMR data
indicate no major structural changes in the helical portion of the
fragments with the inclusion of the extra 7 residues in SP-B (1–
25,63–78) (see below). Since NMR gives residue-specific informa-
tion on secondary structure and CD reports on the fraction of
residues in a particular structure, both results are consistent with
the same number of residues taking on a helical structure in the
two peptides. However, the CD data provide no clear indication of
the structural preferences of these extra 7 residues, which is
consistent with the known difficulties in extracting anything but
the fraction of helical structure from CD spectra of this wavelength
range [57]. The ContinLL deconvolution suggests the additional
residues in SP-B (1–25,63–78) take on mainly a mix of unordered
and b-sheet conformations, but the K2D analysis is more
consistent with the extra residues forming exclusively unordered
structures. A peptide consisting of SP-B (1–7) by itself was also
subjected to CD analysis in both SDS micelles (Figure 3) and in
40% hexafluoroisopropanol (HFIP) (data not shown). However,
the peptide was poorly soluble and the secondary structure
deconvolution unreliable due to the poor signal-to-noise in the
spectrum and the difficulties in reliably determining the effective
concentration, and thus the deconvolution data has not been
included in the analysis.
Figure 5. Selected regions of 2D NOESY NMR spectra of 1 mM
SP-B (1–25,63–78) in 150 mM SDS solution at pH 5 and 456C
(red) and 1 mM SP-B (8–25,63–78) in 150 mM SDS at pH 5 and
376C (blue).
doi:10.1371/journal.pone.0072821.g005
Table 3. Partial 1H chemical shift assignments (in ppm) for
residues 1–7 of SP-B, as assigned based on 2D TOCSY and
NOESY NMR experiments with SP-B (1–7) and SP-B (1–25,63–
78) (Super Mini-B) in deuterated SDS at 45uC.
Residue NH Ha Hb Hother
F1 7.66 4.52 3.45, 3.24 Hd= 7.67, He= 7.32
Hf=7.55
P2/4/6 N/A 3.85 1.78, 2.12 Hc= 1.29,1.55,
Hd= 3.66,3.18,
P2/4/6 N/A 4.38 1.77, 2.28 Hc= 1.94,1.78,
Hd= 3.47,3.24
P2/4/6 N/A 4.53 2.04, 2.14 Hc= 1.54,1.16,
Hd= 3.79,3.45
I3 unassigned 3.65 1.74 Hc2= 0.99
L5 7.31 4.52 2.05, 2.22 Hc= 1.91,
Hd= 0.94,0.95
Y6 7.10 4.51 3.07, 2.74 Hd= 7.10, He= 6.96
Note that although three sets of proline resonances were identified, none of
them could be identified with a particular proline in the sequence.
doi:10.1371/journal.pone.0072821.t003
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Solution NMR experiments were also used to assess the
conformation of SP-B (1–25,63–78) in SDS micelles. 1D proton,
2D-TOCSY and 2D-NOESY NMR experiments were acquired at
several temperatures. 45uC was chosen for analysis because this
temperature provided the greatest peak intensity and resolution.
The HN region of the 1D 1H NMR spectrum of SP-B (1–25,63–
78) in SDS micelles at 45uC (Figure S1) is shown along with a
spectrum of SP-B (8–25,63–78) in SDS micelles at 37uC
(Figure 4). The overall dispersion of peaks in the HN region is
similar, implying a similar level of structuring for both peptides.
However in the SP-B (1–25,63–78) spectrum the peaks appear
broader.
2D TOCSY (Figure S2) and NOESY (Figure S3) NMR
spectra were acquired for the SP-B (1–25,63–78)/SDS samples. In
Figure 5, selected regions of the NOESY spectra are displayed
overlaid on previously acquired spectra of SP-B (8–25,63–78) [40].
As in the 1D NMR spectra, the peaks in the 2D spectra of SP-B
(1–25,63–78) are broad compared to those from SP-B (8–25,63–
78). Given the unique amino acid composition of the insertion
sequence, it was possible to use the SP-B (1–25,63–78) spectra,
along with spectra of SP-B (1–7) acquired under identical
conditions (Figures S4 and S5), to obtain partial resonance
assignments for this region (Table 3). The peaks for the regions
outside residues 1–7 in the SP-B (1–25,63–78) spectra overlay
reasonably well with the strong peaks in the SP-B (8–25,63–78)
spectra. In particular, the strong HN-HN peaks that are indicative
of a-helical structure [58] are retained in the SP-B (1–25,63–78)
spectra. Overall the similarity in peak positions between the two
peptides indicates that the presence of the insertion sequence does
not modify the structure of the remainder of the peptide, at least
not substantially enough to detect given the differences in
conditions and lineshape between the two spectra.
There are two possible explanations for the greater linewidth of
1D and 2D NMR spectra of SP-B (1–25,63–78) compared to the
spectra from SP-B (8–25,63–78). One is that there is an increase in
the size of the SP-B (1–25,63–78)/SDS micelle complexes being
observed, compared to the complexes formed with SP-B (8–25,63–
78). Alternatively, the broader lines could derive from conforma-
tional fluctuations on the millisecond to microsecond timescale
[59].
Peptide Self Association
In order to explore the possibility that there is a substantial
increase in the size of SP-B (1–25,63–78) complexes, we used
diffusion NMR spectroscopy to measure the apparent translational
diffusion constant at 37uC. As seen in Figure 6, the diffusion
constants observed in the HN/aromatic region, and thus deriving
from the peptide, are in the range of 3 to 4610210 m2s21. The
apparent diffusion constants derived from the detergent peaks are
similar. The apparent diffusion constant measured previously for
SP-B (8–25,63–78) in SDS micelles at the same temperature was
2.760.3610210 m2s21 [60]. Thus, the diffusion measurements
imply that SP-B (1–25,63–78) is in similar sized complexes or
slightly smaller complexes compared to SP-B (8–25,63–78). To
further test the possibility that the increase in linewidth might
derive from an increase in self-association of the peptide, we
performed titration experiments in which 1D NMR spectra of SP-
B (1–25,63–78) were acquired at increasing peptide concentrations
(data not shown). No changes in the spectra with peptide
concentration were observable.
Discussion
To explore the role of the N-terminal 7 residues of SP-B, we first
used 2H NMR to examine the effect of SP-B (1–25,63–78) on
mechanically oriented lipid bilayers composed of a mixture of
zwitterionic and anionic phospholipids, POPC-d31/POPG (7:3)
(Figure 1). The presence of SP-B (1–25,63–78), a fragment which
contains the N-terminal 7 residues as well as the first and last
helices of SP-B, caused a substantial effect on the 2H NMR
splittings and hence acyl chain orientational order, particularly
deep in the bilayer (Table 1). The magnitude of the SP-B (1–
25,63–78)-induced effect was particularly striking when compared
to the effect of SP-B (8–25,63–78) [55], i.e. an identical peptide
except for the absence of residues 1–7. 1 mol% SP-B (8–25,63–78)
induced only a slight decrease in splitting (Figure 2), compared to
the much more marked effect of 1 mol% SP-B (1–25,63–78). More
quantitatively, the order parameters, SCD, calculated from the
splittings (Table 1) for the acyl chain positions just adjacent to the
terminal methyl group decreased with the addition of 1 mol% SP-
B (1–25,63,78) by 18%, 20% and 17% for C15, C14, and C13,
respectively. On the other hand, the decrease in the same order
parameters with 1 mol% SP-B (8–25,63,78) were less than 1%. In
earlier studies, we also measured the reduction in POPC/POPG-
d31 order parameter induced by the C-terminal helix alone [61].
The lowest peptide concentration studied in that work was
2.4 mol% SP-B (63–78) and this reduced the order parameters
calculated for positions C13, C14, and C15 of POPC-d31 by 7.4%,
7.5%, and 6.3% respectively - i.e. less than half the disruption of
SP-B (1–25,63–78) with more than twice the peptide. Thus, it
appears that residues 1–7 of SP-B cause a dramatic decrease in
acyl chain orientational order, especially towards the centre of the
bilayer.
The ability of the N-terminal 7 residues of SP-B to disrupt order
deep within the bilayer could be an important component of SP-
B’s suggested function in mediating transfer of lipids between the
surfactant monolayer at the surface and the underlying multilay-
ers. Mutation of the N-terminal prolines to alanines in SP-B (1–25)
leads to less effective reinsertion of surface-active material into the
expanding interface film [44] and deletion of the insertion
sequence from SP-B (1–25), reduces this peptide’s ability to
promote the formation of a fluid isotropic phase in the lipids [62].
When a peptide substantially reduces the orientational order of
the lipid chains, in particular deep in the bilayer, this indicates that
the peptide locates close to the polar/apolar interface [61,63].
Figure 6. DOSY NMR analysis of SuperMini-B in SDS micelles at
376C.
doi:10.1371/journal.pone.0072821.g006
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This is because a peptide positioned close to the lipid head groups
can increase the spacing between lipids without constraining the
motions of the acyl chains, that, with the increase in headgroup
spacing, have more orientational freedom. By contrast, peptides
that insert deeply into the bilayer have little effect on acyl chain
order [63,64] because the peptide itself confers stearic constraints
on acyl chain motions. That Super Mini-B (SP-B (1–25,63–78)) is
so effective at disrupting the order deep in the bilayer interior is
thus an indication that the N-terminal 7 residues likely do not
penetrate deeply enough to constrain the amplitude of lipid acyl
chain reorientation. This is not because the 7 residues cannot form
a long enough structure; for an extended conformation such as a
b-strand, the translation per residue is about 3.5 A˚ [65] and so 7
residues could, in theory extend out to 24.5 A˚, which is close to the
width of the hydrophobic region of a lipid bilayer. Instead, it
appears that the insertion sequence residues preferentially position
closer to the surface of the bilayer. Consistent with this
interpretation, fluorescence quenching experiments found that
residues 1–6 of SP-B (1–25) locate near the bilayer surface, while
residues 7–9 insert more deeply [66]. 2D TOCSY and NOESY
solution NMR experiments indicate that the 7 N-terminal residues
do not induce a major change in the structure of the helical regions
of the protein. This is inferred by the absence in major changes in
the positions of the peaks from SP-B (8–25,63–78) in the context of
SP-B (1–25,63–78) (Figure 5). This NMR result backs up
previous studies in which FTIR spectra indicated little difference
in helical content between SP- B (8–25,63–78) and SP-B (1–25,63–
78) [42].
Despite the apparent absence of alterations in helicity, the
solution NMR spectra of SP-B (1–25,63–78) (Figures 4 and 5)
did exhibit an increase in linewidth compared to spectra of SP-B
(8–25,63–78) consistent with an increase in the size of the peptide/
SDS micelle and/or an increase in dynamics on an intermediate
timescale. Dimerization of SP-B (1–25,63–78) was previously
suggested on the basis of SDS-PAGE electrophoresis [42].
However, diffusion NMR measurements (Figure 6) indicate that
the size of the SP-B (1–25,63–78)/SDS complexes is similar to that
previously measured for SP-B (8–25,63–78) complexes and
titration experiments also failed to provide evidence of peptide
self-association. Thus, the most likely explanation for the increase
in linewidth is a change in the global dynamics of SP-B (1–25,63–
78) compared to SP-B (8–25,63–78). An increase in dynamics on
the millisecond to microsecond timescale would account for the
increase in line widths [59] and would also be consistent with the
increase in motional flexibility of the lipid chains observed in the
2H-NMR experiments.
The insertion sequence contains three proline residues and thus
we wanted to explore the possibility that a polyproline helical
structure is formed. The circular dichroism data does not clearly
indicate what type of structure this 7-residue piece forms –
although as expected the CD spectra do exclude a- or 310 helix
(Table 2, Figure 3). The CD spectra are not inconsistent with
the 7 residues taking on a polyproline helical type secondary
structure in that while the spectrum of SP-B (8–25,63–78) exhibits
a canonical helical shape, with minima at 209 nm and 220 nm,
the spectrum of SP-B (1–25,63–78) displays an altered shape with
a slight shift of the 209 minimum to a shorter wavelength and a
less pronounced minimum at 220 nm. However, the deconvolu-
tion of the CD spectra (Table 2) suggests the insertion sequence
could also consist of a large portion of b and/or unordered
structures.
In summary, we report that the 7-residue insertion sequence of
SP-B does not substantially disrupt the helical region of the
peptide, but does cause alterations in the solution NMR line-
width, most likely via alterations in the global mobility of the
peptide We also find that the inclusion of the insertion sequence
leads to dramatic increases in acyl chain disorder in the centre of
the bilayer, as compared to the more modest degree of disorder
produced by SP-B peptides lacking the insertion sequence. This
degree of acyl chain disruption is consistent with a location of the
insertion sequence close to the bilayer surface and is likely
important in promoting the bilayer disruptions important to SP-
B’s role in adsorption and re-spreading of lung surfactant.
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